*Kazuya Iwamoto¹ (1. Department of Molecular Brain Science, Graduate School of Medical Sciences, Kumamoto University)

*Tomohiro Yoshida¹, Masahito Nakataki¹, Syusuke Numata¹ (1. Tokushima University Graduate School of Medicine, Department of Psychiatry)

*Satoshi Okazaki¹, Ikuo Otsuka¹, Takaki Tanifuji¹, Toshiyuki Shirai¹, Kentaro Mouri¹, Akitoyo Hishimoto¹ (1. Kobe University Graduate School of Medicine, Department of Psychiatry)

*Takehiko Yamanashi¹, Gen Shinozaki² (1. Tottori University Hospital, Department of psychiatry, 2. Stanford University, Department of Psychiatry and Behavioral Sciences)

*Masahiko Tomiyama¹, Haruo Nishijima¹ (1. Department of Neurology, Hirosaki University Graduate School of Medicine)

*Atsushi Nambu¹ (1. National Institute for Physiological Sciences)

*Hiroyoshi Takeuchi¹ (1. Department of Neuropsychiatry, Keio University School of Medicine)

*Kenji F Tanaka¹ (1. Keio University School of Medicine, Division of Brain Sciences)

*Yuki Kurauchi¹ (1. Department of Chemico-Pharmacological Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University)

*Masahiro Ohsawa¹, Yasumi Ohta², Metin Akay³, Ohta Jun² (1. Laboratory of Systems Pharmacology, Faculty of Pharmaceutical Sciences, Teikyo University, 2. Division of Materials Science, Graduate School of Science and Technology, Nara Institute of Science and Technology, 3. Biomedical Engineering Department, University of Houston)

*Daisuke Uta¹ (1. Department of Applied Pharmacology, Faculty of Pharmaceutical Sciences, University of Toyama)

*Takeshi Kawano¹ (1. Institute for Research on Next-generation Semiconductor and Sensing Science (IRES2))

*櫻井 武¹ (1. 筑波大学 国際統合睡眠医科学研究機構)

*Ryoichi Sadahiro¹, Hiromichi Matsuoka¹ (1. National Cancer Center Japan, National Cancer Center Hospital, Department of Psycho-oncology)

*南雲 康行¹ (1. 国立がん研究センター研究所　がん患者病態生理研究ユニット)

*Kazuo Yamada¹ (1. Division of Psychiatry, Tohoku Medical and Pharmaceutical University Hospital)

*Shin-ichi Muramatsu¹ (1. Oriental Medicine, Jichi Medical University)

*Ichiro Arai¹ (1. Nihon Pharmacetical University)

*Haruhisa Ohta¹ (1. Showa University Medical Institute of Developmental Disabilities Research)

*Hori Hikaru¹ (1. Department of Psychiatry, Faculty of Medicine, Fukuoka University)

*Hiroyoshi Takeuchi¹ (1. Department of Neuropsychiatry, Keio University School of Medicine)

*Kentaro Kohno¹ (1. Department of Psychiatry, Oita University Faculty of Medicine )

*Jun-ichi Iga¹ (1. Department of Neuropsychiatry, Ehime University Graduate School of Medicine)

*Taku Maruki¹ (1. Department of Neuropsychiatry, Kyorin University School of Medicine)

*Yuka Takahashi¹ (1. Tokyo Women's Medical University Hospital pharmaceutical department)

*Masanobu Ito¹ (1. Department of Psychiatry, Juntendo University Faculty of Medicine)

*Saya Kikuchi¹ (1. Department of Psychiatry, Tohoku University Hospital)

*Kiyotaka Nemoto¹ (1. Department of Psychiatry, Institute of Meidicne, University of Tsukuba)

*Haruhiko Ogata¹ (1. Department of Neuropsychiatry, Kansai Medical University)

*飯田 仁志¹ (1. 福岡大学医学部精神医学教室)

*Masahiko Kawano¹ (1. Miyakonojo shinsei hospital)

*Hiroyuki Muraoka¹ (1. Department of Psychiatry, School of Medicine, Kitasato University)

*Masahide USAMI¹ (1. Department of Child and Adolescent Psychiatry, Kohnodai Hospital, National Center for Global Health and Medcine)

*Takashi Okada¹ (1. Department of Psychiatry, Nara Medical University)

*Noriko Kimura¹ (1. NANIWA IKUNO HOSPITAL Dept. of Psychomatic Medicine)

*Kensuke Nomura^1,2 (1. Shimada Ryoiku Medical Center for Challenged Children, 2. Department of Neuropsychiatry, School of Medicine, Keio University)

*Hideaki Tani¹ (1. Department of Neuropsychiatry, Keio University School of Medicine)

*Daisuke Ibi¹ (1. Department of Chemical Pharmacology, Meijo University)

*Tomoya Sugai¹ (1. International Institute for Integrative Sleep medicine, University of Tsukuba)

*Atsuhito Toyomaki¹ (1. Department of Psychiattry , Hokkaido University)

*Takashi Tsuboi¹ (1. Department of Neuropsychiatry, Kyorin University School of Medicine)

*Hikaru Hori¹ (1. Department of Psychiatry, Faculty of Medicine, Fukuoka University)

*MEGUMI YAMAMOTO^1,2 (1. Shonan occupational health consultant office, 2. Japan Depression center)

*Hirohisa Watanabe¹ (1. Department of Neurology, Fujita Health University, School of Medicine)

*Shinsuke Ishigaki¹ (1. Molecular Neuroscience Research Center, Shiga University of Medical Science )

*Akihiro Mouri^1,3, Kazuo Kunisawa¹, Toshitaka Nabeshima^2,3 (1. Department of Regulatory Science for Evaluation and Development of Pharmaceuticals and Devices, Fujita Health University Graduate School of Health Sciences., 2. Laboratory of Health and Medical Science Innovation, Fujita Health University Graduate School of Health Sciences., 3. Japanese Drug Organization of Appropriate Use and Research.)

*Nobuhisa Iwata^1,2, Takaomi C. Saido² (1. Department of Genome-based Drug Discovery, Graduate School of Biomedical Sciences Nagasaki University, 2. RIKEN Center for Brain Science)

*Kenji Hashimoto¹ (1. Chiba University Center for Forensic Mental Health)

*Keiko Takasu¹, Yosuke Yawata¹, Ryoichi Tashima¹, Hiroyuki Aritomi², Shinji Shimada², Tomoko Motomiya¹, Koichi Ogawa¹ (1. Shionogi & Co., Ltd, 2. Shionogi TechnoAdvance Research)

*Hiroe Hara¹ (1. Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited)

*Hiroyuki Koike¹, Ichiro Horinokita¹, Reiko Yasufuku¹, Mikio Suzuki¹, Takeo Funakoshi¹, Takashi Futamura¹ (1. Department of CNS Research, Otsuka Pharmaceutical Co., Ltd.)

*Yukari Suda^1,2, Michiko Narita², Yuki Sugiura³, Naoko Kuzumaki^1,2, Minoru Narita^1,2 (1. Dept. Pharmacol., Hoshi Univ., 2. Div. Pathophysiol., Natl. Cancer Ctr. Res. Inst., 3. Center for Cancer Immunotherapy and Immunobiology, Kyoto Univ. Sch. Med.)

*余宮 きのみ¹ (1. 埼玉県立がんセンター　緩和ケア科)

*Takatoshi Hirayama^1,2 (1. Kokoro Support Clinic, 2. Department of Psycho-Oncology, National Cancer Center Hospital)

*Noritaka Nakamichi¹ (1. Faculty of Pharmacy, Takasaki University of Health and Welfare)

*Tsugunobu Andoh¹ (1. College of Pharmacy, Kinjo Gakuin University)

*Sumiko Hyuga¹ (1. Laboratory of Kampo Clinical Research, Oriental Medicine Research Center, School of Pharmacy, Kitasato University)

*Chihiro Tohda¹, Ximeng Yang¹, Yuna Inada¹ (1. Section of Neuromedical Science, Institute of Natural Medicine, University of Toyama)

*Hidenori Yamasue¹ (1. Department of Psychiatry, Hamamatsu University School of Medicine)

*Eiji Shigetomi^1,2, Schuichi Koizumi^1,2 (1. Yamanashi GLIA center, Interdiscipl Grad Sch Med, Univ Yamanashi, 2. Dept Neuropharmacol, Interdiscipl Grad Sch Med, Univ Yamanashi)

*Takahiro A. Kato¹ (1. Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University)

*Hidetomo Murakami¹ (1. Department of Neurology, Showa University School of Medicine)

*Taiji Tsunemi¹, Nobutaka Hattori¹ (1. Juntendo Uninversity)

*Masahiko Tomiyama¹, Haruo Nishijia¹ (1. Department of Neurology, Hirosaki University Graduate School of Medicine)

*Takashi Tsuboi¹ (1. Department of Neuropsychiatry, Kyorin University School of Medicine)

*Hiroyoshi Takeuchi¹ (1. Department of Neuropsychiatry, Keio University School of Medicine)

*Takekita Yoshiteru¹ (1. Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University)

*内匠 透¹ (1. 神戸大学大学院医学研究科生理学・細胞生物学講座)

*Koki Mimura^1,2, jumpei Matsumoto³, Daichi Mochihashi¹, Tomoaki Nakamura⁴, Hisao Nishijo³, Takafumi Minamimoto² (1. The Institute of Statistical Mathematics, 2. National Institutes for Quantum Science and Technology, 3. University of Toyama, 4. The University of Electro-Communications)

*Jumpei Matsumoto¹ (1. System Emotional Science, University of Toyama)

*Hajime Baba¹ (1. Department of Psychiatry, Juntendo University Koshigaya Hospital)

*Yoshikazu Takaesu¹ (1. Department of Neuropsychiatry, Graduate School of Medicine, University of the Ryukyus)

*Masahiro Takeshima¹ (1. Department of Neuropsychiatry, Akita University Graduate School of Medicine)

*Jun-ichi Iga¹ (1. Department of Neuropsychiatry, Ehime University Graduate School of Medicine)

*Shinichiro Ochi¹ (1. Department of Neuropsychiatry, Ehime University Graduate School of Medicine)

*Yuta Yoshino¹ (1. Department of psychiatry, Ehime University)

*Noa TSUJII¹ (1. Child Mental Health and Development, Toyama University Hospital)

*motonori yokoyama¹ (1. sapporo ekimae clinic hokkaido rework plaza)

*Takashi Okada¹ (1. Department of Psychiatry, Nara Medical University)

*Hiroshige Fujishiro¹ (1. Department of Psychiatry, Nagoya University Graduate School of Medicine)

*Takehiko Yamanashi¹, Gen Shinozaki² (1. Tottori University Hospital, Department of psychiatry, 2. Stanford University, Department of Psychiatry and Behavioral Sciences)

*Kotaro Hatta¹ (1. Juntendo University Nerima Hospital)

*Hiroyoshi Takeuchi¹ (1. Department of Neuropsychiatry, Keio University School of Medicine)

*Mihoko Kawai¹, Kousuke Kanemoto¹ (1. Department of Neuropsychiatry, Aichi Medical University)

*Koichiro Hara¹ (1. Department of Psychiatry, Asai Hospital)

*Hirotaka Iwaki¹, Izumi Kuramochi², Go Taniguchi³ (1. DouOusato Hospital, 2. Department of Neuropsychiatry, Saitama Medical Center, Saitama Medical University, 3. National Center Hospital, National Center of Neurology and Psychiatry)

*Kanemoto Kousuke¹ (1. Chubu PNES Research Center)

*Yuta Yoshino¹ (1. Department of psychiatry, Ehime University)

*Hajime Baba¹ (1. Department of Psychiatry, Juntendo University Koshigaya Hospital)

*Jun-ichi Iga¹ (1. Department of Neuropsychiatry, Ehime University Graduate School of Medicine)

*Takekita Yoshiteru¹ (1. Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University)

*Takekita Yoshiteru¹ (1. Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University)

*Toshiaki Kikuchi¹ (1. Keio University School of Medicine)

*Hirofumi Hirakawa¹ (1. Department of Neuropsychiatry, Oita University Faculty of Medicine)

*Takeshi Ikeuchi¹ (1. Brain Research Institute, Niigata University)

*Taku Hatano¹, Ayami Okuzumi¹, Nobutaka Hattori¹ (1. Department of Neurology, Juntendo University School of Medicine)

*樋口 真人¹ (1. 国立研究開発法人量子科学技術研究開発機構量子生命・医学部門量子医科学研究所　脳機能イメージング研究部)

*Kazuhiko Yamamuro¹ (1. Department of Psychiatry, Nara Medical University)

*Atsushi Kasai¹ (1. Nagoya University, Research Institute of Environmental Medicine)

*Hiroshi Nomura¹ (1. Nagoya City University Graduate School of Medical Sciences)

*Shigeki Moriguchi¹ (1. RCPD, Grad. Sch. Pharmaceut. Sci. Tohoku Univ.)

*Itaru Kushima^1,2 (1. Department of Psychiatry, Nagoya University Graduate School of Medicine, 2. Medical Genomics Center, Nagoya University Hospital)

*Yuko Arioka^1,2, Hiroki Okumura^1,3 (1. Pathophysiology of Mental Disorders, Nagoya University Graduate School of Medicine, 2. Nagoa University Hospital, CAMCR, 3. Nagoa University Hospital, Pharmacy)

*Koh-ichi Nagata¹, Nanako Hamada¹, Hidenori Ito¹, Hidenori Tabata¹ (1. Institute for Developmental Research, Aichi Developmental Disability Center)

*Yukihiro Noda¹ (1. Div Clin Sci & Neuropsychopharmacol, Grad Sch Pharm, Meijo Univ)

*Kenjiro Ono¹ (1. Department of Neurology, Kanazawa University Graduate School of Medical Sciences)

*Takayoshi Shimohata¹ (1. Department of Neurology, Gifu University Graduate School of Medicine)

*Takafumi Hasegawa¹ (1. NHO Sendai Nishitaga Hospital)

*Hiroyuki Muraoka¹, Ochi Shinichiro², Yasushi Kawamata³, Daisuke Koshiyama⁴, Toru Horinouchi⁵ (1. Department of Psychiatry, School of Medicine, Kitasato University, 2. Department of Neuropsychiatry, Ehime University Graduate School of Medicine, 3. Department of Psychiatry, Dokkyo Medical University School of Medicine, 4. Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, 5. Department of Psychiatry, Hokkaido University Graduate School of Medicine)

*Yoshitaka Saito¹ (1. Department of Psychiatry Kitasato University, School of Medicine)

*Kenta Ide¹ (1. Department of Hospital Pharmacy, Hospital of University of Occupational and Environmental Health)

*Hiroki Takahashi¹ (1. Hirosaki Aiseikai Hospital)

*Aki Nemoto¹ (1. Dokkyo Medical University Hospital Nursing Department)

*Kazuo Kunisawa¹, Toshitaka Nabeshima^2,3, Akihiro Mouri^1,3 (1. Dept. Regulatory Sci., Grad. Sch. Health Sci., Fujita Health Univ., 2. HMSI, Grad. Sch. Health Sci., Fujita Health Univ. , 3. NPO, J-DO.)

*Ryota Araki¹ (1. Laboratory of Functional Biomolecules and Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Setsunan University)

*Yoki Nakamura¹, Kazue Hisaoka-Nakashima¹, Norimitsu Morioka¹ (1. Grad Sch Biomed Health Sci, Hiroshima Univ)

*Akira Yamashita^1,2 (1. Department of Medical Neuropharmacology, Wakayama Medical University, School of Pharmaceutical Sciences, 2. Department of Physiology1, Kagoshima University, Graduate School of Medical and Dental Sciences)

*Shun Igarashi^1,2, Shinsuke Kito^1,3 (1. Department of Psychiatry, National Center Hospital, National Center of Neurology and Psychiatry, 2. Department of Neuropsychiatry, Kyorin University Faculty of Medicine, 3. Department of Psychiatry, Jikei University School of Medicine)

*Yuki Matsuda^1,2,3, Shinsuke Kito^2,3 (1. Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine/School of Public Health , 2. Department of Psychiatry, Jikei University School of Medicine, 3. Department of Psychiatry, National Center Hospital, National Center of Neurology and Psychiatry)

*Takamasa Noda¹ (1. National Center of Neurology and Psychiatry)

*Shinsuke Kito^1,2 (1. Department of Psychiatry, National Center Hospital, National Center of Neurology and Psychiatry, 2. Department of Psychiatry, Jikei University School of Medicine)

*Kazuyuki Yasuda¹ (1. University of Yamanashi Faculty of Medicine, Department of Neuropsychiatry)

*Taro Suwa¹ (1. Department of Psychiatry, Graduate School of Medicine, Kyoto University)

*Hirotsugu Kawashima¹ (1. Department of Psychiatry, Kyoto University Hospital)

*Hisashi Narita¹ (1. Department of psychiatry and Neurology, Hokkaido University Hospital)

*Naoya Kida¹ (1. National hospital organization Ryukyu Hospital)

*Kentaro Mizuno¹ (1. Kisaragikai Medical Corporation Wakakusa Hospital)

*Yuki Kako¹ (1. Forensic Psychiatry Center, Hokkaido University Hospital )

*Yuya Mizuno^1,2,3 (1. Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, 2. TREAT Service, South London & Maudsley NHS Foundation Trust, 3. Department of Neuropsychiatry, Keio University School of Medicine)

*Shuhei Ishikawa¹ (1. Department of psychiatry, Hokkaido university hospital)